Evolent Health, Inc Class A Common Stock (EVH) is a publicly traded Healthcare sector company. As of November 6, 2026, EVH trades at $4.48 with a market cap of $542.68M and a P/E ratio of -0.85. EVH moved -1.41% today. Year to date, EVH is +14.84%; over the trailing twelve months it is -28.57%. Its 52-week range spans $2.10 to $12.07. Analyst consensus is buy with an average price target of $5.56. Rallies surfaces EVH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
11 analysts cover EVH: 0 strong buy, 8 buy, 3 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $5.56.
| Metric | Value |
|---|---|
| Price | $4.48 |
| Market Cap | $542.68M |
| P/E Ratio | -0.85 |
| EPS | $-4.57 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.07 |
| 52-Week Low | $2.10 |
| Volume | 10 |
| Avg Volume | 0 |
| Revenue (TTM) | $2.10B |
| Net Income | $-511.06M |
| Gross Margin | 17.25% |
11 analysts cover EVH: 0 strong buy, 8 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.56.